The Journal of Experimental Medicine
for flow cytometry > invitrogen
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online 5 March 2001.
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 298K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baker, B. M.
Right arrow Articles by Biddison, W. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baker, B. M.
Right arrow Articles by Biddison, W. E.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*(L)-ALANINE
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
© The Rockefeller University Press, 0022-1007/2001/3/551/ $5.00
The Journal of Experimental Medicine, Volume 193, Number 5, March 5, 2001 551-562


Original Article

Identification of a Crucial Energetic Footprint on the {alpha}1 Helix of Human Histocompatibility Leukocyte Antigen (Hla)-A2 That Provides Functional Interactions for Recognition by Tax Peptide/Hla-A2–Specific T Cell Receptors

Brian M. Bakera, Richard V. Turnerc, Susan J. Gagnonc, Don C. Wileya,b, and William E. Biddisonc

a Department of Molecular and Cellular Biology, Harvard University, Cambridge, Massachusetts 02138
b Howard Hughes Medical Institute, Cambridge, Massachusetts 02138
c Molecular Immunology Section, Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892
National Institutes of Health, Bldg. 10, Rm. 5B-16, Bethesda, MD 20892.301-402-0373301-496-9009

web{at}helix.nih.gov

Structural studies have shown that class I major histocompatibility complex (MHC)-restricted peptide-specific T cell receptor (TCR)-{alpha}/βs make multiple contacts with the {alpha}1 and {alpha}2 helices of the MHC, but it is unclear which or how many of these interactions contribute to functional binding. We have addressed this question by performing single amino acid mutagenesis of the 15 TCR contact sites on the human histocompatibility leukocyte antigen (HLA)-A2 molecule recognized by the A6 TCR specific for the Tax peptide presented by HLA-A2. The results demonstrate that mutagenesis of only three amino acids (R65, K66, and A69) that are clustered on the {alpha}1 helix affected T cell recognition of the Tax/HLA-A2 complex. At least one of these three mutants affected T cell recognition by every member of a large panel of Tax/HLA-A2–specific T cell lines. Biacore measurements showed that these three HLA-A2 mutations also altered A6 TCR binding kinetics, reducing binding affinity. These results show that for Tax/HLA-A2–specific TCRs, there is a location on the central portion of the {alpha}1 helix that provides interactions crucial to their function with the MHC molecule.

Key Words: T cell receptor • major histocompatibility complex class I–peptide complex • T cell activation • CD8+ T cell • binding kinetics


Abbreviations used in this paper: CD, circular dichroism; MIP, macrophage inflammatory protein.

© 2001 The Rockefeller University Press


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS